-+ 0.00%
-+ 0.00%
-+ 0.00%

GERON CORPORATION SHARES FALL 17.3% AFTER CO DISCONTINUES LATE-STAGE TRIAL OF BLOOD CANCER DRUG

Reuters·10/28/2026 13:34:03

Please log in to view news